Abstract
Rationale
High-affinity, slow-onset, long-acting dopamine transporter (DAT) inhibitors are being considered as potential agonist replacement therapies for cocaine addiction, and therefore the ability of these drugs to reinstate cocaine seeking and to selectively decrease cocaine-maintained responding should be assessed.
Objectives
The purpose of these experiments was to evaluate the effects of the active enantiomer of a high-affinity, slow-onset, long-acting DAT inhibitor, (−)2β-propanoyl-3β-(4-tolyl)-tropane (PTT), and cocaine on food- and cocaine-maintained responding and on extinguished responding previously maintained by cocaine in non-human primates using a within-subjects design.
Methods
Rhesus monkeys (n=3) responded under a multiple fixed-ratio schedule of food (1 g) and drug reinforcement, and cocaine dose-response curves (saline, 0.003–0.3 mg/kg per injection) were determined. The effects of pretreatment with (−)PTT (0.001–0.056 mg/kg, IV) and cocaine (0.03–0.3 mg/kg, IV) were determined when the dose of cocaine that maintained peak response rates (0.03 mg/kg per injection) or saline was available.
Results
(−)PTT and cocaine reduced cocaine intake; (−)PTT affected cocaine self-administration only at doses that also decreased food-maintained responding. (−)PTT and cocaine reinstated responding that was previously reinforced by cocaine at lower doses than were necessary to decrease cocaine-maintained responding. For all studies, PTT was at least 1.0 log-unit more potent than cocaine. Compared to cocaine, PTT had a longer duration of action in all behavioral measures.
Conclusions
These results suggest that PTT would decrease cocaine use, but only at doses that disrupted other behaviors. It appears that the potency of this class of drugs to reinstate cocaine-seeking is substantially greater than their potency at decreasing cocaine self-administration.
Similar content being viewed by others
References
Bennett BA, Wichems CH, Hollingsworth CK, Davies HML, Thornley C, Sexton T, Childers SR (1995) Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J Pharmacol Exp Ther 272:1176–1186
Birmingham AM, Nader SH, Grant KA, Davies HML, Nader MA (1998) Further evaluation of the reinforcing effects of the novel cocaine analog 2β-propanoyl-3-β-(4-tolyl)-tropane (PTT) in rhesus monkeys. Psychopharmacology 136:139–147
Davies HML, Saikali E, Sexton T, Childers SR (1993) Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur J Pharmacol 244:93–97
de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134–143
Dews PB (1958) Studies on behavior IV. Stimulant actions of methamphetamine. J Pharmacol Exp Ther 122:137–147
Dworkin SI, Lambert P, Sizemore GM, Carroll FI, Kuhar MJ (1998) RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse 30:49–55
Elangovan N, Barbato M, Cooper T, Winsberg B (1996) Neurohormonal and behavioral response to methylphenidate in cocaine abstinence. Psychiatry Res 65:65–71
Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128:408–412
Gerber GJ, Stretch R (1975) Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol Biochem Behav 3:1055–1061
Glowa JR, Wojnicki FHE, Matecka D, Bacher JD, Mansbach RS, Balster RL, Rice KC (1995a) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219–231
Glowa JR, Wojnicki FHE, Matecka D, Rice KC, Rothman RB (1995b) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations. Exp Clin Psychopharmacol 3:232–239
Glowa JR, Fantegrossi WE, Lewis DB, Matecka D, Rice KC, Rothman RB (1996) Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl)piperazinyl decanoate, a long-acting ester derivative of GBR 12909. J Med Chem 39:4689–4691
Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1–6
Howell LL, Czoty PW, Kuhar MJ, Carrol FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521–529
Hughes JR, Goldstein MG, Hurt RD, Shiffman S (1999) Recent advances in the pharmacotherapy of smoking. JAMA 281:72–76
Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97:59–64
Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21–30
Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1–56
Klein M (1998) Research issues related to development of medications for treatment of cocaine addiction. Ann NY Acad Sci 844:75–91
Lile JA, Nader MA (2003) The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Curr Neuropharmacol 1:21–46
Lile JA, Morgan D, Freedland CS, Sinnott RS, Davies HM, Nader MA (2000) Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology 152:414–421
Lile JA, Morgan D, Birmingham AM, Davies HML, Nader MA (2002) The reinforcing efficacy of the dopamine reuptake inhibitor PTT as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys. J Pharmacol Exp Ther 303:640–648
Ludwig AM, Wikler A (1974) “Craving” and relapse to drink. Q J Stud Alcohol 35:108–130
Mansbach RS, Balster RL (1993) Effects of mazindol on behavior maintained or occasioned by cocaine. Drug Alcohol Depend 31:183–191
Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163–182
Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375–424
Nader MA, Grant KA, Davies HML, Mach RH, Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2-β-propanoyl-3-β-(4-tolyl)-tropane (PTT) in rhesus monkeys. J Pharmacol Exp Ther 280:541–550
Negus SS, Mello NK (2003) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39–52
Porrino LJ, Davies HML, Childers SR (1995) Behavioral and local cerebral metabolic effects of the novel tropane analog, 2β-propanoyl-3-β-(4-tolyl)-tropane. J Pharmacol Exp Ther 272:901–910
Schenk S (2002) Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology 160:263–270
Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin seeking in rats under opioid maintenance: the effects of stress, heroin priming and withdrawal. J Neurosci 16:1957–1963
Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42
Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327–336
Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N (1999) Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry 156:19–26
Ward J, Hall W (1999) Role of maintenance treatment in opioid dependence. Lancet 353:221–226
Weissenborn R, Yackey M, Koob GF, Weiss F (1995) Measures of cocaine-seeking behavior using a multiple schedule of food and drug self-administration in rats. Drug Alcohol Depend 38:237–246
Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13–22
Acknowledgements
The authors thank D.R. Claytor, C.L. Hubbard and J.T. Ross for technical assistance, Drs. P. Ren and T. Gregg for the synthesis of (−)PTT, Drs. J.R. Tobin and R. Sherertz for consultation regarding catheter tract infection prevention, A. Ruggerio for assistance with statistical analysis and Dr. P. Czoty for comments on an earlier version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lile, J.A., Morgan, D., Birmingham, A.M. et al. Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys. Psychopharmacology 174, 246–253 (2004). https://doi.org/10.1007/s00213-003-1738-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1738-x